Intellectual disability, X-linked, with or without seizures, ARX-related

MONDO:0010317

Also known as: ARX-related intellectual disability, intellectual developmental disorder, X-linked 29, X-linked recessive, intellectual disability, X-linked, with or without seizures, ARX-related, MRX52, MRXARX, intellectual disability, X-linked 29, intellectual disability, X-linked 32, intellectual disability, X-linked 33

1 clinical trial for this condition and its sub-types, 1 tagged with Intellectual disability, X-linked, with or without seizures, ARX-related itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Non-syndromic X-linked intellectual disability (3)

Including sub-types (1) Tagged with Intellectual disability, X-linked, with or without seizures, ARX-related (1)

Not yet finished but already full! 1

New cancer drug IDE161 enters human testing

Disease control Ongoing

This early-stage trial is testing a new drug called IDE161, alone or with the immunotherapy pembrolizumab, in adults with advanced solid tumors (like breast, ovarian, prostate, or lung cancer). The main goals are to check safety, find the right dose, and get a first look at wheth…

Phase 1 • Sponsor: IDEAYA Biosciences • Aim: Disease control

Last updated Jul 15, 2026 00:00 UTC

Intellectual disability, X-linked, with or without seizures, ARX-related

Where it sits in the disease tree

New cancer drug IDE161 enters human testing